ADCY10 and neoplasm: Since PARPis and PP2Ais target the 2 different mechanisms of DNA damage repair defects and SAC activation silencing in BRCA2-deficient tumor cells, we speculated that the combined use of PARPi and PP2Ai should have prominent advantages.